These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27476929)

  • 1. Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
    Tostevin A; White E; Dunn D; Croxford S; Delpech V; Williams I; Asboe D; Pozniak A; Churchill D; Geretti AM; Pillay D; Sabin C; Leigh-Brown A; Smit E;
    HIV Med; 2017 Mar; 18(3):204-213. PubMed ID: 27476929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
    Ross LL; Shortino D; Shaefer MS
    AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.
    Sayan M; Sargin F; Inan D; Sevgi DY; Celikbas AK; Yasar K; Kaptan F; Kutlu S; Fisgin NT; Inci A; Ceran N; Karaoglan I; Cagatay A; Celen MK; Koruk ST; Ceylan B; Yildirmak T; Akalın H; Korten V; Willke A
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):26-31. PubMed ID: 26414663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.
    Ross L; Lim ML; Liao Q; Wine B; Rodriguez AE; Weinberg W; Shaefer M
    HIV Clin Trials; 2007; 8(1):1-8. PubMed ID: 17434843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
    Alexiev I; Shankar A; Wensing AM; Beshkov D; Elenkov I; Stoycheva M; Nikolova D; Nikolova M; Switzer WM
    J Antimicrob Chemother; 2015; 70(6):1874-80. PubMed ID: 25652746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
    Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
    Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study.
    ; Dolling D; Sabin C; Delpech V; Smit E; Pozniak A; Asboe D; Brown AL; Churchill D; Williams I; Geretti AM; Phillips A; Mackie N; Murphy G; Castro H; Pillay D; Cane P; Dunn D; Dolling D
    BMJ; 2012 Aug; 345():e5253. PubMed ID: 22915687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.
    Margot NA; Wong P; Kulkarni R; White K; Porter D; Abram ME; Callebaut C; Miller MD
    J Infect Dis; 2017 Mar; 215(6):920-927. PubMed ID: 28453836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Baxter JD; Dunn D; White E; Sharma S; Geretti AM; Kozal MJ; Johnson MA; Jacoby S; Llibre JM; Lundgren J;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):77-87. PubMed ID: 25711326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
    Mbunkah HA; Marzel A; Schmutz S; Kok YL; Zagordi O; Shilaih M; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Kouyos RD; Günthard HF; Metzner KJ
    J Antimicrob Chemother; 2018 Jul; 73(7):1917-1929. PubMed ID: 29635462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV-1 transmitted drug resistance in the incarcerated population.
    Sapozhnikov J; Young JD; Patel M; Chiampas TD; Vaughn P; Badowski ME
    HIV Med; 2017 Nov; 18(10):756-763. PubMed ID: 28585361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
    Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
    PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary.
    Áy É; Müller V; Mezei M; Pocskay Á; Koroknai A; Müller D; Győri Z; Marschalkó M; Tóth B; Kárpáti S; Lakatos B; Szlávik J; Takács M; Minárovits J
    J Glob Antimicrob Resist; 2020 Mar; 20():124-130. PubMed ID: 31330377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.
    Trebelcock WL; Lama JR; Duerr A; Sanchez H; Cabello R; Gilada T; Segura P; Reisner SL; Mayer KH; Mullins J; Bender Ignacio RA
    J Int AIDS Soc; 2019 Nov; 22(11):e25411. PubMed ID: 31773888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan.
    Lai CC; Liu WC; Fang CT; Yang JY; Chang LH; Wu PY; Luo YZ; Chang SF; Su YC; Chang SY; Hung CC
    J Antimicrob Chemother; 2016 Jan; 71(1):226-34. PubMed ID: 26404079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.